Can prior vaccinations against certain infections confer protection against developing melanoma?

被引：6

作者：

Grange, John M.

Krone, Bernd ^{[1
]}

Koelmel, Klaus F. ^{[1
]}

Mastrangelo, Giuseppe ^{[2
]}

机构：

[1] Univ Gottingen, Gottingen, Germany

[2] Univ Padua, Padua, Italy

来源：

MEDICAL JOURNAL OF AUSTRALIA | 2009年 / 191卷 / 09期

关键词：

MALIGNANT-MELANOMA; EPIDEMIOLOGY; VACCINIA; RISK; BCG;

D O I：

10.5694/j.1326-5377.2009.tb02907.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：478 / 479

页数：2

共 10 条

[1]

*AUSTR I HLTH WELF, 2007, CANC SERIES AIHW, V37

[2] Melanoma epidemiology and trends [J].

Garbe, Claus ;

Leiter, Ulrike .

CLINICS IN DERMATOLOGY, 2009, 27 (01) :3-9

[3] Immunotherapy for malignant melanoma - Tracing Ariadne's thread through the labyrinth [J].

Grange, John M. ;

Krone, Bernd ;

Stanford, John L. .

EUROPEAN JOURNAL OF CANCER, 2009, 45 (13) :2266-2273

[4] Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival.: An European Organization for Research and Treatment of Cancer cohort study on 542 patients [J].

Kölmel, KF ;

Grange, JM ;

Krone, B ;

Mastrangelo, G ;

Rossi, CR ;

Henz, BM ;

Seebacher, C ;

Botev, IN ;

Niin, M ;

Lambert, D ;

Shafir, R ;

Kokoschka, EM ;

Kleeberg, UR ;

Gefeller, O ;

Pfahlberg, A .

EUROPEAN JOURNAL OF CANCER, 2005, 41 (01) :118-125

[5] Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia:: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control [J].

Krone, B ;

Kölmel, KF ;

Henz, BM ;

Grange, JM .

EUROPEAN JOURNAL OF CANCER, 2005, 41 (01) :104-117

[6] Impact of vaccinations and infectious diseases on the risk of melanoma -: evaluation of an EORTC case-control study [J].

Krone, B ;

Kölmel, KF ;

Grange, JM ;

Mastrangelo, G ;

Henz, BM ;

Botev, IN ;

Niin, M ;

Seebacher, C ;

Lambert, D ;

Shafir, R ;

Kokoschka, EM ;

Kleeberg, UR ;

Gefeller, O ;

Pfahlberg, A .

EUROPEAN JOURNAL OF CANCER, 2003, 39 (16) :2372-2378

[7] Does yellow fever 17D vaccine protect against melanoma? [J].

Mastrangelo, G. ;

Krone, B. ;

Fadda, E. ;

Buja, A. ;

Grange, J. M. ;

Rausa, G. ;

de Vries, E. ;

Koelmel, K. F. .

VACCINE, 2009, 27 (04) :588-591

[8]

Maurer S, 1997, MONOGRAPH CANC RES I, V19

[9]

Schiavetti F, 2002, CANCER RES, V62, P5510

[10] The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation [J].

Serafino, A. ;

Balestrieri, E. ;

Pierimarchi, P. ;

Matteucci, C. ;

Moroni, G. ;

Oricchio, E. ;

Rasi, G. ;

Mastino, A. ;

Spadafora, C. ;

Garaci, E. ;

Vallebona, P. Sinibaldi .

EXPERIMENTAL CELL RESEARCH, 2009, 315 (05) :849-862

← 1 →